SE8801708D0 - New use of dopamine receptor agonists - Google Patents

New use of dopamine receptor agonists

Info

Publication number
SE8801708D0
SE8801708D0 SE8801708A SE8801708A SE8801708D0 SE 8801708 D0 SE8801708 D0 SE 8801708D0 SE 8801708 A SE8801708 A SE 8801708A SE 8801708 A SE8801708 A SE 8801708A SE 8801708 D0 SE8801708 D0 SE 8801708D0
Authority
SE
Sweden
Prior art keywords
receptor agonists
dopamine receptor
new use
lergotrile
lisuride
Prior art date
Application number
SE8801708A
Other languages
English (en)
Other versions
SE8801708L (sv
Inventor
P S Muller
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8801708D0 publication Critical patent/SE8801708D0/sv
Publication of SE8801708L publication Critical patent/SE8801708L/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE8801708A 1987-05-07 1988-05-05 Ny anvaendning av dopamnreceptoragonister SE8801708L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4775387A 1987-05-07 1987-05-07

Publications (2)

Publication Number Publication Date
SE8801708D0 true SE8801708D0 (sv) 1988-05-05
SE8801708L SE8801708L (sv) 1988-11-08

Family

ID=21950776

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8801708A SE8801708L (sv) 1987-05-07 1988-05-05 Ny anvaendning av dopamnreceptoragonister

Country Status (13)

Country Link
JP (1) JPS63287723A (sv)
KR (1) KR880013556A (sv)
AU (1) AU622614B2 (sv)
CH (1) CH675834A5 (sv)
DE (1) DE3814521A1 (sv)
DK (1) DK245388A (sv)
FR (1) FR2614789B1 (sv)
GB (1) GB2204240B (sv)
IT (1) IT1219564B (sv)
NL (1) NL8801171A (sv)
PH (1) PH25495A (sv)
SE (1) SE8801708L (sv)
ZA (1) ZA883237B (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797405A (en) * 1987-10-26 1989-01-10 Eli Lilly And Company Stabilized pergolide compositions
US6623752B1 (en) 1996-07-02 2003-09-23 Hexal Ag Patch for transdermal application for pergolid
DE19626621A1 (de) * 1996-07-02 1998-01-08 Hexal Ag Pflaster zur transdermalen Anwendung von Pergolid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR861128B (en) * 1985-05-06 1986-08-26 Sandoz Ag New use of dopamine agonists
DE3722383A1 (de) * 1986-07-14 1988-01-28 Sandoz Ag Neue verwendung von bromocriptin

Also Published As

Publication number Publication date
AU1560588A (en) 1988-11-10
DK245388D0 (da) 1988-05-05
GB2204240A (en) 1988-11-09
JPS63287723A (ja) 1988-11-24
DK245388A (da) 1988-11-08
DE3814521A1 (de) 1988-11-17
FR2614789B1 (fr) 1991-10-18
SE8801708L (sv) 1988-11-08
IT1219564B (it) 1990-05-18
NL8801171A (nl) 1988-12-01
PH25495A (en) 1991-07-24
IT8847906A0 (it) 1988-05-03
KR880013556A (ko) 1988-12-21
GB2204240B (en) 1991-04-24
FR2614789A1 (fr) 1988-11-10
ZA883237B (en) 1990-01-31
GB8810509D0 (en) 1988-06-08
AU622614B2 (en) 1992-04-16
CH675834A5 (sv) 1990-11-15

Similar Documents

Publication Publication Date Title
NO910187D0 (no) Fremgangsmaate for fremstilling av indolsubstituerte, heteroaromatiske femringforbindelser.
DE69925024D1 (de) Verwendung von eph-rezeptor-antagonisten und agonisten zur behandlung von vaskulären krankheiten
DK59182A (da) Farmaceutiske midler med kontinuerlig frigoerelse
IT1219906B (it) Impieghi in terapeutica degli agonisti dei recettori dopaminergici
DE69414398D1 (de) Heterocyclische neurokinin-antagonisten
AR016217A1 (es) Composicion farmaceutica que comprende un modulador dispositivo de un agonista receptor nicotinico, metodo para el tratamiento de un trastorno asociado conuna transmision reducida de nicotina, metodo para identificar un agonista repector nicotinico, uso de un modulador positivo de un agonista recept
IS3284A7 (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
SI1202727T1 (sv)
SE8801708D0 (sv) New use of dopamine receptor agonists
SE8400445D0 (sv) Novel pharmaceutical active 1,2,3,4,4a,5,10,10a-octahydrobenzo(g)quinoline derivatives, their production and use
IT1203782B (it) Impiego in terapeutica degli agonisti dopaminergici
ES2098263T3 (es) 8-alfa-acilamino-ergolinas, su preparacion y su utilizacion como medicamentos.
NL172616C (nl) Werkwijze voor het bereiden van stabiele oplossingen voor oraal gebruik van gehydrogeneerde moederkoornalkaloiden.
ES469908A1 (es) Procedimiento de utilizacion de salinomicina.
EP0417637A3 (en) Use of dopamine autoreceptor agonists in the treatment of drug dependency
DK480979A (da) Fremgangsmaade til fremstilling af 9,10-dihydro-4h-benzo(4,5)cyclohepta(1,2-b)thiophen-4,9-iminer
IT8948215A0 (it) Impiego in terapeutica dei derivati della benzo (g) chinolina per il trattamento della dipendenza della nicotina
BG50187A1 (en) Solid medicinal form on the basis of ergoalkaloid derivatides
NO164544C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive hydrazonderivater med morfinan-skjelett.
IT8922778A0 (it) Dispositivo per l'applicazione della ionoforesi nella cura dell'impotenza maschile, in particolare per la cura dell'impotenza erettile

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8801708-2

Effective date: 19911125

Format of ref document f/p: F